Fak loss had minimal impact on tumor incidence in the small intestine and the colon; however, it greatly enhanced BRAFV600E-induced cecal tumor formation: cecal tumor incidence increased from 0% (0/15) in 9-month or older BC mice to 100% (16/16) in FBC mice (Fig. 2c). Here, PTK2 is linked to breast cancer.